The dynamics of the eosinophilic esophagitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as APT-1011 (Ellodi Pharmaceuticals), tezepelumab (AstraZeneca,) and ESO-101 (EsoCap) during the forecast period (2024–2034). LAS...
Read More Details
Finally We wish PressBee provided you with enough information of ( Eosinophilic Esophagitis Market Set to Surge as New Research Unveils Breakthrough Treatments .. DelveInsight )
Also on site :
- EU country tells citizens how to spot Russian spies
- Elk Grove police release video of officer shooting armed suspect in In-N-Out parking lot
- Who is Yuval Raphael? Meet Israel's Eurovision 2025 entry